Oxnard G - Search Results

1

Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.

Powles T, Young A, Nimeiri H, Madison RW, Fine A, Zollinger DR, Huang Y, Xu C, Gjoerup OV, Aushev VN, Wu HT, Aleshin A, Carter C, Davarpanah N, Degaonkar V, Gupta P, Mariathasan S, Schleifman E, Assaf ZJ, Oxnard G, Hegde PS. Powles T, et al. Among authors: oxnard g. Front Oncol. 2023 Jul 31;13:1221718. doi: 10.3389/fonc.2023.1221718. eCollection 2023. Front Oncol. 2023. PMID: 37601688 Free PMC article.

2

Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumab.

Kansara M, Bhardwaj N, Thavaneswaran S, Xu C, Lee JK, Chang LB, Madison RW, Lin F, Hsu E, Patel VK, Aleshin A, Oxnard GR, Simes J, Nimeiri H, Thomas DM. Kansara M, et al. Mol Oncol. 2023 Feb;17(2):298-311. doi: 10.1002/1878-0261.13349. Epub 2022 Dec 13. Mol Oncol. 2023. PMID: 36426653 Free PMC article.

3

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors.

Lee JK, Sivakumar S, Schrock AB, Madison R, Fabrizio D, Gjoerup O, Ross JS, Frampton GM, Napalkov P, Montesion M, Schutzman JL, Ye X, Hegde PS, Nagasaka M, Oxnard GR, Sokol ES, Ou SI, Shi Z. Lee JK, et al. NPJ Precis Oncol. 2022 Dec 9;6(1):91. doi: 10.1038/s41698-022-00334-z. NPJ Precis Oncol. 2022. PMID: 36494601 Free PMC article.

4

A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.

Assaf ZJF, Zou W, Fine AD, Socinski MA, Young A, Lipson D, Freidin JF, Kennedy M, Polisecki E, Nishio M, Fabrizio D, Oxnard GR, Cummings C, Rode A, Reck M, Patil NS, Lee M, Shames DS, Schulze K. Assaf ZJF, et al. Nat Med. 2023 Apr;29(4):859-868. doi: 10.1038/s41591-023-02226-6. Epub 2023 Mar 16. Nat Med. 2023. PMID: 36928816 Free PMC article.

5

Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing.

Tung N, Dougherty KC, Gatof ES, DeLeonardis K, Hogan L, Tukachinsky H, Gornstein E, Oxnard GR, McGregor K, Keller RB. Tung N, et al. NPJ Precis Oncol. 2023 Aug 11;7(1):76. doi: 10.1038/s41698-023-00429-1. NPJ Precis Oncol. 2023. PMID: 37568048 Free PMC article.

6

Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.

Mack PC, Keller-Evans RB, Li G, Lofgren KT, Schrock AB, Trabucco SE, Allen JM, Tolba K, Oxnard GR, Huang RSP. Mack PC, et al. Among authors: oxnard gr. Oncologist. 2024 Feb 24:oyae028. doi: 10.1093/oncolo/oyae028. Online ahead of print. Oncologist. 2024. PMID: 38401173 Free article.

7

Genomic landscape of 891 RET fusions detected across diverse solid tumor types.

Parimi V, Tolba K, Danziger N, Kuang Z, Sun D, Lin DI, Hiemenz MC, Schrock AB, Ross JS, Oxnard GR, Huang RSP. Parimi V, et al. NPJ Precis Oncol. 2023 Jan 23;7(1):10. doi: 10.1038/s41698-023-00347-2. NPJ Precis Oncol. 2023. PMID: 36690680 Free PMC article.

8

Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.

Burns L, Tukachinsky H, Raskina K, Huang RSP, Schrock AB, Sands J, Kulke MH, Oxnard GR, Tapan U. Burns L, et al. Among authors: oxnard gr. Lung Cancer. 2024 Feb;188:107454. doi: 10.1016/j.lungcan.2023.107454. Epub 2023 Dec 29. Lung Cancer. 2024. PMID: 38159439 Free article.

9

Not all TMB assays are the same: Clinical validity of robust algorithmic germline filtering.

Huang RSP, Graf RP, Oxnard GR. Huang RSP, et al. Cancer Cell. 2023 May 8;41(5):819-820. doi: 10.1016/j.ccell.2023.03.017. Epub 2023 Apr 13. Cancer Cell. 2023. PMID: 37059103 Free article.

10

Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma.

Muthusamy B, Raskina K, Lofgren KT, Li G, Tolba K, Schwed K, Castellanos E, Huang RSP, Oxnard GR, Schrock AB, Pennell N. Muthusamy B, et al. Among authors: oxnard gr. J Thorac Oncol. 2023 Apr;18(4):476-486. doi: 10.1016/j.jtho.2022.11.027. Epub 2022 Dec 6. J Thorac Oncol. 2023. PMID: 36494074 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page